Adjusting for abiraterone-prednisone cross-over in de novo metastatic castration-sensitive prostate cancer: a post-hoc analysis of the PEACE-1 trial

Rousseau, Adrien; Karimi, Maryam; Michiels, Stefan; Roubaud, Guilhem; Maldonado, Xavier; Supiot, Stephane; McDermott, Ray; Flechon, Aude; Tombal, Bertrand; Ronchin, Philippe; Berthold, Dominik; Berdah, Jean-François; Kacso, Gabriel; Gravis, Gwenaelle; Calabro, Fabio; Tartas, Sophie; Muracciole, Xavier; Ribault, Helene; Fizazi, Karim; Foulon, Stéphanie

doi:10.1016/j.ejca.2025.116024

Adjusting for abiraterone-prednisone cross-over in de novo metastatic castration-sensitive prostate cancer: a post-hoc analysis of the PEACE-1 trial

Rousseau, Adrien

;

Karimi, Maryam

;

Michiels, Stefan

;

Roubaud, Guilhem

;

Foulon, Stéphanie

;et.al.

(2025) European Journal of Cancer — Vol. 230, p. 116024 (2025)

Files

Rousseau41045691.pdf

Open Access
Adobe PDF
1.32 MB

Download

Details

Authors

Rousseau, Adrien
Author
Karimi, Maryam
Author
Michiels, Stefan
Author
Roubaud, Guilhem
Author
Tombal, BertrandUCLouvain
Author
Foulon, Stéphanie
Author

Affiliations

UCLouvainSSS/IREC - Institut de recherche expérimentale et clinique

Citations

APA
Chicago
FWB

Rousseau, A., Karimi, M., Michiels, S., Roubaud, G., Maldonado, X., Supiot, S., McDermott, R., Flechon, A., Tombal, B., Ronchin, P., Berthold, D., Berdah, J.-F., Kacso, G., Gravis, G., Calabro, F., Tartas, S., Muracciole, X., Ribault, H., Fizazi, K., & Foulon, S. (2025). Adjusting for abiraterone-prednisone cross-over in de novo metastatic castration-sensitive prostate cancer: a post-hoc analysis of the PEACE-1 trial. European Journal of Cancer, 230, 116024. https://doi.org/10.1016/j.ejca.2025.116024 (Original work published 2025)